<DOC>
	<DOCNO>NCT00939939</DOCNO>
	<brief_summary>The goal study evaluate whether sitagliptin affect postprandial lipoprotein metabolism type 2 diabetic patient .</brief_summary>
	<brief_title>Effect Sitagliptin Postprandial Lipoprotein Metabolism</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Glimepiride</mesh_term>
	<mesh_term>Sitagliptin Phosphate</mesh_term>
	<criteria>type 2 diabetes dietary therapy lipidlowering therapy antihyperglycemic drug therapy</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>July 2009</verification_date>
</DOC>